By 2060, a quarter of U.S. residents will be over age 65 By MIKE SCHNEIDER Apnews.com - By 2060, almost a quarter of all U.S. residents will be over age 65, and life expectancy will reach an all-time high of 85 years, according to new reports the U.S. Census Bureau released Thursday. The growth in life
Author: Editor
Volume 10, Issue 19: Kara A. Connor, SVP Clinical Operations, MediGuide International LLC Discusses the Importance and Simplicity of Getting a Medical Second Opinion (MSO)
Dear Colleagues, Medical Travel Today is excited to bring you an interview with Kara A. Connor, SVP Clinical Operations, MediGuide International LLC, a company that provides a medical second opinion (MSO) service reflecting the best advice from the top medical minds at world-leading medical centers. In this interview, read how MediGuide
Spotlight Interview: Kara A. Connor, SVP Clinical Operations, MediGuide International LLC
About Kara A. Connor, SVP Clinical Operations, MediGuide International LLC As SVP of Clinical Operations, Kara leads the team responsible for connecting MediGuide members to world leading medical centers and providing them answers to their health concerns. A key role which she not only provides clinical leadership but also focuses on cultivating relationships with centers
Industry News: Volume 10, Issue 19
INDUSTRY NEWS This Coronavirus Is Unlike Anything in Our Lifetime, and We Have to Stop Comparing It to the Flu by Charles Ornstein Propublica.com - As a longtime health care reporter, I see the unfolding coronavirus pandemic as representing everything I’ve read about — from the early days of epidemiology to the staggering toll of the 1918 Spanish Flu pandemic —
VOLUME 4 ISSUE 2: Jonathan Wiesen, MD, CMO, MediOrbis, LLC Discusses the Growing Impact of Telehealth and Chronic Disease Management
Dear Colleagues, In this issue, I had the chance to speak with Jonathan Wiesen, MD, CMO, MediOrbis, LLC, a multi-specialty telemedicine and telehealth company that is shattering the barriers of traditional medicine and extending the reach of specialized clinical care and chronic disease management (CDM) to its global customer base. In
Spotlight Interview: Jonathan Wiesen, MD, CMO, MediOrbis, LLC
About Jonathan Wiesen, MD: Dr. Jonathan Wiesen is a Pulmonary and Critical Care physician passionate about clinical medicine, innovation and medical technology. Dr. Wiesen graduated from the Albert Einstein College of Medicine with distinction in research and completed his training in internal medicine and pulmonary/critical care at the Cleveland Clinic, where he earned an advanced teaching
Industry News: Volume 4 Issue 2
Price hikes drove employer-sponsored health costs to record high in 2018by Hailey Mensik healthcaredive.com - The vast majority of Americans receive health coverage through their employer and HCCI's annual report found health spending growth exceeded 4% for the third consecutive year. The report comes as the presidential election brings more focus on the healthcare
Volume 10, Issue 18: Daniel Branco, MD, Medicinia, Discusses the Importance of Connecting Doctors and Patients and Technology to Increase Patient Engagement
Dear Colleagues, Medical Travel Today is excited to bring you an interview with Daniel Branco, Medicinia, a client relationship management platform company that connects doctors, patients, and health institutions to create better opportunities for patient engagement. In this interview, Branco explains how technology can help doctors stay productive and keep patients
Spotlight Interview: Daniel Branco, M.D., Founder, Medicinia
-- Daniel Branco Founder +1 (305) 927-4226 About Daniel Branco, M.D., Founder, Medicinia Daniel Branco is founder of Medicinia and investor in other digital health companies such as DrChat. After building the very first medical website in Brazil (an atlas of human histology) back in 1995, he was involved with many health care investment and business
Industry News: Volume 10, Issue 18
INDUSTRY NEWS More drugmakers hike U.S. prices as new year begins By Michael Erman reuters.com – Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by